HCAR2 | Hydroxycarboxylic acid receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HCAR3 | Hydroxycarboxylic acid receptor 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HRH1 | Histamine receptor H1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HRH2 | Histamine receptor H2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HRH3 | Histamine receptor H3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
HTR1F | 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
HTR6 | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
HTR7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LHCGR | Luteinizing hormone/choriogonadotropin receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MC2R | Melanocortin 2 receptor (adrenocorticotropic hormone) | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MTNR1A | Melatonin receptor 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
MTNR1B | Melatonin receptor 1B | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
NTSR2 | Neurotensin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
OPRD1 | Opioid receptor, delta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OPRK1 | Opioid receptor, kappa 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
OXTR | Oxytocin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
P2RY2 | Purinergic receptor P2Y, G-protein coupled, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTGER1 | Prostaglandin E receptor 1 (subtype EP1), 42kDa | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PTGER2 | Prostaglandin E receptor 2 (subtype EP2), 53kDa | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
PTGER3 | Prostaglandin E receptor 3 (subtype EP3) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
PTGER4 | Prostaglandin E receptor 4 (subtype EP4) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTGFR | Prostaglandin F receptor (FP) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PTGIR | Prostaglandin I2 (prostacyclin) receptor (IP) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
PTH2R | Parathyroid hormone 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
S1PR5 | Sphingosine-1-phosphate receptor 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SCTR | Secretin receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMO | Smoothened, frizzled family receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Mixed |
SSTR1 | Somatostatin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SSTR2 | Somatostatin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SSTR5 | Somatostatin receptor 5 | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Not detected |
TAAR1 | Trace amine associated receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
TACR1 | Tachykinin receptor 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
TBXA2R | Thromboxane A2 receptor | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
TSHR | Thyroid stimulating hormone receptor | Cancer-related genes Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |